<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 656    </title>
<shortdesc>PRESCRIP DRUG ETHICAL MRKT ACT</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Jack D. Franks-Eddie Washington-Michael K. Smith-John D'Amico, Linda Chapa LaVia and Karen A. Yarbrough</sponsors>
</sponsor>
<lastaction>
<statusdate>1/9/2007</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><SynopsisText>     Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose.</SynopsisText><synopsistitle>House Amendment No. 1</synopsistitle>
<SynopsisText>Deletes everything. Inserts provisions substantially similar to those of HB 656, except: provides that "labeler" does not include a retail pharmacy or pharmacist that labels a prescription vial; and excludes pharmacists from language requiring manufacturers and labelers to disclose gifts, fees, payments, subsidies, and other economic benefits to certain persons.</SynopsisText></synopsis>
<actions>
<statusdate>1/28/2005</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Jack D. Franks</action>
<statusdate>1/31/2005</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>1/31/2005</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/3/2005</statusdate><chamber>House</chamber><action>Assigned to Registration and Regulation Committee</action>
<statusdate>2/9/2005</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Linda Chapa LaVia</action>
<statusdate>2/24/2005</statusdate><chamber>House</chamber><action>House Amendment No. 1 Filed with Clerk by Registration and Regulation Committee</action>
<statusdate>2/24/2005</statusdate><chamber>House</chamber><action>House Amendment No. 1 Adopted in Registration and Regulation Committee;  by Voice Vote</action>
<statusdate>2/24/2005</statusdate><chamber>House</chamber><action>Motion Do Pass as Amended - Lost Registration and Regulation Committee;  002-013-005</action>
<statusdate>2/24/2005</statusdate><chamber>House</chamber><action>Remains in Registration and Regulation Committee</action>
<statusdate>3/2/2005</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Karen A. Yarbrough</action>
<statusdate>3/10/2005</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>3/16/2005</statusdate><chamber>House</chamber><action>Chief Co-Sponsor Rep. Eddie Washington</action>
<statusdate>3/16/2005</statusdate><chamber>House</chamber><action>Chief Co-Sponsor Rep. Michael K. Smith</action>
<statusdate>3/16/2005</statusdate><chamber>House</chamber><action>Chief Co-Sponsor Rep. John D'Amico</action>
<statusdate>1/9/2007</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

